These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 12445480

  • 1. Inhibitors alter the spectrum and redox properties of monoamine oxidase A.
    Ramsay RR, Hunter DJ.
    Biochim Biophys Acta; 2002 Dec 16; 1601(2):178-84. PubMed ID: 12445480
    [Abstract] [Full Text] [Related]

  • 2. Monoamine oxidase A inhibitory potency and flavin perturbation are influenced by different aspects of pirlindole inhibitor structure.
    Hynson RM, Wouters J, Ramsay RR.
    Biochem Pharmacol; 2003 Jun 01; 65(11):1867-74. PubMed ID: 12781338
    [Abstract] [Full Text] [Related]

  • 3. Structure-activity relationships in the oxidation of para-substituted benzylamine analogues by recombinant human liver monoamine oxidase A.
    Miller JR, Edmondson DE.
    Biochemistry; 1999 Oct 12; 38(41):13670-83. PubMed ID: 10521274
    [Abstract] [Full Text] [Related]

  • 4. Loss of serotonin oxidation as a component of the altered substrate specificity in the Y444F mutant of recombinant human liver MAO A.
    Nandigama RK, Miller JR, Edmondson DE.
    Biochemistry; 2001 Dec 11; 40(49):14839-46. PubMed ID: 11732903
    [Abstract] [Full Text] [Related]

  • 5. Investigation on the structure of the active site of monoamine oxidase-B by affinity labeling with the selective inhibitor lazabemide and by site-directed mutagenesis.
    Cesura AM, Gottowik J, Lahm HW, Lang G, Imhof R, Malherbe P, Röthlisberger U, Da Prada M.
    Eur J Biochem; 1996 Mar 15; 236(3):996-1002. PubMed ID: 8665924
    [Abstract] [Full Text] [Related]

  • 6. Substrates but not inhibitors alter the redox potentials of monoamine oxidases.
    Sablin SO, Ramsay RR.
    Antioxid Redox Signal; 2001 Oct 15; 3(5):723-9. PubMed ID: 11761322
    [Abstract] [Full Text] [Related]

  • 7. Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines.
    Vintém AP, Price NT, Silverman RB, Ramsay RR.
    Bioorg Med Chem; 2005 May 16; 13(10):3487-95. PubMed ID: 15848762
    [Abstract] [Full Text] [Related]

  • 8. Influence of flavin analogue structure on the catalytic activities and flavinylation reactions of recombinant human liver monoamine oxidases A and B.
    Miller JR, Edmondson DE.
    J Biol Chem; 1999 Aug 13; 274(33):23515-25. PubMed ID: 10438531
    [Abstract] [Full Text] [Related]

  • 9. Alteration in spectral properties on ligand binding reveals flexibility in monoamine oxidase.
    Ramsay RR, Jones TZ, Hynson RM.
    Med Sci Monit; 2005 Sep 13; 11(9):SR15-20. PubMed ID: 16127378
    [Abstract] [Full Text] [Related]

  • 10. [Mechanistic study of monoamine oxidase: significance for MAO A and MAO B in situ].
    Ramsay RR.
    Vopr Med Khim; 1997 Sep 13; 43(6):457-70. PubMed ID: 9503563
    [Abstract] [Full Text] [Related]

  • 11. Resonance Raman spectroscopic evidence for an anionic flavin semiquinone in bovine liver monoamine oxidase.
    Yue KT, Bhattacharyya AK, Zhelyaskov VR, Edmondson DE.
    Arch Biochem Biophys; 1993 Jan 13; 300(1):178-85. PubMed ID: 8424650
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. ONIOM calculations on serotonin degradation by monoamine oxidase B: insight into the oxidation mechanism and covalent reversible inhibition.
    Cakir K, Erdem SS, Atalay VE.
    Org Biomol Chem; 2016 Oct 21; 14(39):9239-9252. PubMed ID: 27605388
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Orientation of oxazolidinones in the active site of monoamine oxidase.
    Jones TZ, Fleming P, Eyermann CJ, Gravestock MB, Ramsay RR.
    Biochem Pharmacol; 2005 Aug 01; 70(3):407-16. PubMed ID: 15950194
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phentermine inhibition of recombinant human liver monoamine oxidases A and B.
    Nandigama RK, Newton-Vinson P, Edmondson DE.
    Biochem Pharmacol; 2002 Mar 01; 63(5):865-9. PubMed ID: 11911838
    [Abstract] [Full Text] [Related]

  • 18. Catalytic and inhibitor binding properties of zebrafish monoamine oxidase (zMAO): comparisons with human MAO A and MAO B.
    Aldeco M, Arslan BK, Edmondson DE.
    Comp Biochem Physiol B Biochem Mol Biol; 2011 Jun 01; 159(2):78-83. PubMed ID: 21354322
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of dehydropirlindole and other compounds on rat brain monoamine oxidase type A.
    Gerardy J, Dresse A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan 01; 26(1):75-9. PubMed ID: 11853123
    [Abstract] [Full Text] [Related]

  • 20. Experimental and theoretical study of reversible monoamine oxidase inhibitors: structural approach of the active site of the enzyme.
    Wouters J, Moureau F, Vercauteren DP, Evrard G, Durant F, Koenig JJ, Ducrey F, Jarreau FX.
    J Neural Transm Suppl; 1994 Jan 01; 41():313-9. PubMed ID: 7931244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.